CONMED Completes Acquisition of In2Bones Global, Inc.
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it has completed its previously announced acquisition of privately-held In2Bones Global...
Day: June 13, 2022
Outset Medical Announces Shipment Hold on New Tablo Systems for Home Use Pending FDA Review and Clearance of Recent 510(K) Submission
Investor Webcast and Conference Call Scheduled for 5:00 p.m. EST SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset” or...
9 Meters Biopharma to Participate in the 2022 BIO International Convention
RALEIGH, NC / ACCESSWIRE / June 13, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments...
Tivic Health Announces Annual Meeting of Shareholders
SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today...
Blue Goji to Demonstrate Embodied eSports with Expresso, CyberCycle, Embodi Bikes and to Preview Embodied Health Services at IHRSA 2022
AUSTIN, Texas--(BUSINESS WIRE)--Blue Goji®, a health technology company, will host Embodied eSports demonstrations and prize-winning tournaments with its recently-acquired Expresso®,...
Altamira Therapeutics Announces Top-Line Data from AM-125 Phase 2 Study in Acute Vertigo
Significant improvement in balance after four-week treatment with AM-125 20 mg nasal spray vs. placeboStudy provides proof-of-concept for enhancement and...
The Last Clinic Visit Conducted in Promore Pharma’s Phase II Study of Ensereptide
STOCKHOLM, SE / ACCESSWIRE / June 13, 2022 / Promore Pharma (STO:PROMO) (FRA:8T0)STOCKHOLM, 13 June 2022 - Promore Pharma AB...
Jaguar Health Announces Publication of Onco’Zine Article Underscoring the Importance of Controlling Diarrhea in Cancer Patients
Diarrhea is also a prevalent side effect in dogs undergoing cancer treatment; managing diarrhea can be important to maintain successful...
Aytu BioPharma to Participate in the Lytham Partners Summer 2022 Investor Conference
ENGLEWOOD, CO / ACCESSWIRE / June 13, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and...
Poko Innovations Qualify As Finalists Across Multiple Award Categories At World CBD Awards
Cannmed announced as a finalist at the World CBD Awards for Best CBD White Label BrandCanndid announced as a finalist...
Empower Clinics Revenues Increase Substantially
3,000 Tests and appointments completed since June 1st add to increased revenue across divisionsVANCOUVER, BC / ACCESSWIRE / June 13,...
cbdMD, Inc. CEO Steps Down
Martin Sumichrast resigns as CEO, Board MemberCharlotte, North Carolina--(Newsfile Corp. - June 13, 2022) - cbdMD, Inc. (NYSE American: YCBD)...
CENTR Brands Corp Announces Arjan Chima as New Chief Executive Officer
Founder and current CEO Joseph E. Meehan will assume new role as CENTR's Founder and Board Chairman. Founder and current...
Innovaccer Named to AVIA Connect’s Top 50 Companies in Remote Patient Monitoring Report
Innovaccer’s remote patient monitoring has been recognized by AVIA Connect for its role in advancing virtual acute care solutions to...
LENSAR® Receives U.S. FDA Clearance of ALLY™ Adaptive Cataract Treatment System
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced femtosecond laser...
Relief Reports that its U.S. Collaboration Partner has Announced an Update on Breakthrough Designation for Aviptadil
GENEVA, SWITZERLAND / ACCESSWIRE / June 13, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) ("Relief"), a biopharmaceutical company seeking to...